Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression

Transplantation

Volumn 84, Issue 6, 2007, Pages 715-721

  Schwartz, Jason J ^a   Ishitani, Michael B ^b   Weckwerth, Jody ^b   Morgenstern, Bruce ^c   Milliner, Dawn ^b   Stegall, Mark D ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c PHOENIX CHILDREN'S HOSPITAL   (United States)

Author keywords

Acute rejection; Antithymocyte globulin; Chronic rejection; Induction; Kidney transplantation; Pediatric

Indexed keywords

GANCICLOVIR; IOTALAMIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ADOLESCENT; ADOLESCENT HEALTH; ADULT; ARTICLE; BK VIRUS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; ELECTROLYTE DISTURBANCE; EPSTEIN BARR VIRUS; FEMALE; FIBROSIS; GRAFT REJECTION; GRAFT SURVIVAL; HOSPITALIZATION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MORBIDITY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SCHOOL CHILD; SURVIVAL RATE; URINARY TRACT INFECTION; VIRUS INFECTION;

ADOLESCENT; ANTILYMPHOCYTE SERUM; BIOPSY; CHILD; DRUG THERAPY, COMBINATION; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; IOTHALAMIC ACID; KIDNEY TRANSPLANTATION; LENGTH OF STAY; MALE; MYCOPHENOLIC ACID; PREDNISONE; RETROSPECTIVE STUDIES; TACROLIMUS;

EID: 34748841992     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000281907.54832.cb     Document Type: Article

References (27)

1. Milliner, D. Pediatric renal-replacement therapy - coming of age. N Engl J Med 2003; 350: 2637.
2. North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). The NAPRTCS Home Page. Available at: http://spitfire.emmes.com/study/ped/ resources/annlrpt2005.pdf. Accessed December 1, 2005.
3. Meseguer GC, López AV, Boado AV, Simon JM. Immunoprophylaxis with simulect (basiliximab) in pediatric kidney transplant recipients: Results from routine clinical practice at 5 kidney transplant units. Transplant Proc 2003; 35: 1697.
4. Tejani A, Sullivan EK. Higher maintenance cyclosporine dose decreases the risk of graft failure in North American children: A report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 1996; 7: 550.
5. Seikaly M, Ho PL, Emmett L, Tejani A. The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study: Renal transplantation from 1987 through 1998. Pediatr Transplant 2001; 5: 215.
6. Cole EH, Cattran DC, Farewell VT, et al. A comparison of rabbit antithymoctye serum and OKT3 as prophylaxis against renal allograft rejection. Transplantation 1994; 57: 60.
7. Fisher RA, Tchervenkov JI, Schroeder TJ, et al. Efficacy of induction therapy in cadaveric renal transplantation comparing rabbit antithymocyte serum and Minnesota antilymphoblast globulin. Transplant Proc 1991; 21: 1253.
8. Buchler M, Hurault de Ligny B, Madec C, Lebranchu Y. Induction therapy by anti-thymocyte globulin (rabbit) in renal transplantation: A 1-yr follow-up of safety and efficacy. Clin Transplant 2003; 17: 539.
9. Brennan DC, Flavin K, Lowell JA, et al. A randomized, double-bind comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients. Transplantation 1999; 67: 1386.
10. Civti G, Minettti E, Busnach G, et al. Low incidence of acute rejection in kidney grafts treated with initial quadruple therapy: A retrospective analysis comparing two ATGs. Transplant Proc 1998; 30: 1343.
11. Zaltzman JD, Paul LC. Single center experience with thymoglobulin in renal transplantation. Transplant Proc 1997; 29: 27S.
12. Belitsky P, MacDonald AS, Lawen J, et al. Use of rabbit anti-thymocyte globulin for induction immunosuppression in high-risk kidney transplant recipients. Transplant Proc 1997; 29: 16S.
13. Groth T, Tengstrom B. A simple method for the estimation of glomerular filtration rate. Scand J Clin Lab Invest 1977; 37: 39.
14. Schwartz GJ, Gauthier B. A simple estimate of glomerular filtration rate in adolescent boys. J Pediatr 1985; 106: 522.
15. Cosio FG, Grand JP, Larson TS, et al. Kidney allograft fibrosis and atrophy early after living donor transplantation. Am J Transplant 2005; 5: 1130.
16. Ault BH. Short-term outcomes of Thymoglobulin induction in pediatric renal transplant recipients. Pediatr Nephrol 2002; 17: 815.
17. Kamel MH, Mohan P, Little DM, et al. Rabbit antithymocyte globulin as induction immunotherapy for pediatric deceased donor kidney transplantation. J Urol 2005; 174: 703.
18. Hastings MC, Wyatt RJ, Lau KK, et al. Five years' experience with thymoglobulin induction in a pediatric renal transplant population. Pediatr Transplant 2006; 10: 805.
19. Shapiro R. Living donor kidney transplantation in pediatric recipients. Pediatr Transplant 2006; 10: 844.
20. Ishitani M, Isaacs R, Norwood V, et al. Predictors of graft survival in pediatric living-related kidney transplant recipients. Transplantation 2000; 70: 288.
21. Krieger JN, Brem AS, Kaplan MR. Urinary tract infection in pediatric transplantation. Urology 1980; 15: 362.
22. Shapiro R, Demetrius E, Henkie TP, et al. Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation. J Pediatr 2006; 148: 813.
23. Shapiro R, Santlebury VP, Jordan ML, et al. Pediatric renal transplantation under tacrolimus-based monotherapy. Transplantation 1999; 67: 299.
24. Sarwal MM, Yorgin PD, Alexander S, et al. Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. Transplantation 2001; 72: 13.
25. Ellis D. Growth and renal function after steroid-free tacrolimus-based immunosuppression in children with renal transplants. Pediatr Nephrol; 14: 689.
26. Reyes J, Mazreigos GV, Abu-Elmagd K, et al. Intestinal transplantation under tacrolimus monotherapy after preoperative lymphoid depletion with rabbit anti-thymocyte globulin (Thymoglobulin). Am J Transplant 2005; 5: 1430.
27. Starzl TE, Zinkernagel R. Transplantation tolerance from a historical perspective. Nat Rev Immunol 2001; 2: 2339.